DRTB-HDT:一项随机对照试验,针对两种辅助宿主导疗法,用于对利法胺耐药结核病的患者
Nestani Tukvadze1,2, Sehlomola Mashatole3, Anne Jacobs4,5
1Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123, Allschwil, Switzerland. nestani.tukvadze@swisstph.ch.
BMC infectious diseases
|May 28, 2025
概括
目前正在测试两种宿主导疗法 (HDT),以预防耐药结核病患者的肺损伤. 这项研究旨在改善治疗结果,减少结核病导致的长期残疾.
科学领域:
- 临床医学 临床医学
- 传染性疾病 传染性疾病
- 肺部病理学 肺部病理学
背景情况:
- 结核病 (TB) 仍然是一个重大的全球卫生挑战,导致严重的发病率和死亡率.
- 目前的结核病治疗是漫长的,复杂的,耐受性较差,往往导致永久性肺损伤,特别是在耐利辛结核病 (RIF-R TB) 中.
- 现有的RIF-R结核病疗法导致大多数患者在治疗后出现显著的支气管切开和纤维化.
研究的目的:
- 评估两种辅助宿主导疗法 (HDT) 在预防RIF-R结核病患者肺功能障碍方面的疗效.
- 为了确定CC-11050 (dovramilast) 或甲胺是否可以改善肺功能并减少感染负担.
- 评估这些HTT对肺部放射密度变化的影响.
主要方法:
- 一个随机的,受控的,三臂多中心试验,涉及330名RIF-R结核病和不良结果的风险因素的参与者.
- 参与者接受标准的多种药物治疗,实验组接受CC-11050或甲福明作为辅助治疗.
- 共同初级终点包括肺功能 (精神测量) 和时间到稳定的唾液培养转化;CT扫描子研究评估肺辐射密度.
主要成果:
- 这个部分不在所提供的摘要中.
- 这个部分不在所提供的摘要中.
- 这个部分不在所提供的摘要中.
结论:
- 这项研究研究了两种互补的HDT策略:一种是针对减少炎症,另一种是增强宿主细胞抗菌活性.
- 无论是CC-11050还是美特福明,都有临床前和临床数据支持它们的潜在疗效.
- 成功的结果可以通过提高治愈率和减轻长期残疾来增强欧洲打击耐药结核病的能力.
相关概念视频
Pulmonary Tuberculosis V
249
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
249
Pulmonary Tuberculosis IV
212
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
212
Pulmonary Tuberculosis II
389
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
389
Pulmonary Tuberculosis I
335
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
335
Pulmonary Tuberculosis III
459
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
459


